Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: April 29, 2010
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: October 4, 2012